In the present study, LDLR(−/−) and APOE*3 Leiden mice, two models sensitive to liver steatosis were allowed to develop NASH for 12 weeks on high fat-high cholesterol diet and were subsequently treated with AMP-DNM for 6 weeks. Here, LDLR is linked to metabolic dysfunction-associated steatohepatitis.